Menu
Written by:
This report reviews research detailing the financial and social impacts of national pharmacare implementation abroad, and shifts in policy in Canada. It finds that implementing pharmacare for at least the 80 most commonly prescribed generic drugs would save governments almost a quarter of a billion dollars annually, while allowing everyone who needs those medicines to access them at little or no cost.
 |
 |
 |
Share:
Office:
Project:
Issues:
READ THE FULL REPORT HERE. OTTAWA—Implementing the first phases of a national pharmacare program would significantly lower costs to taxpayers, while improving health outcomes and…
In any public discussion of health care in Canada, the question of wait-times will inevitably come to the fore. For many, wait-times have come to…
The CCPA is Canada’s leading progressive policy research institute. Donors provide core funding for our work. We provide tax receipts.
WAYS TO GIVE
